Several studies place copeptin as one of the most promising strong and independent biomarkers in ischemic stroke that predicts functional outcomes (Katan et al., 2009; De Marchis et al., 2013; Dong et al., 2013; Tu et al., 2013; Zhang et al., 2013; Wang C.-W. The gene discussed is AVP; the disease is ischemic stroke.